Jon Congleton - President and CEO, Nivalis Therapeutics, Inc

As of September 14, 2016


Jon Congleton Net Worth

  • Net worth is estimated to be at least $77.38K
  • Owns at least 20,000 units of Nivalis Therapeutics, Inc stock

Jon Congleton Trading

  • Largest purchase of shares was 5,000 units , worth over $40.5K on December 14, 2015
  • In total has made about 6 transactions over a year
  • Usually trades in March and September, with the busiest year in 2016
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Jon Congleton Mailing Address

  • Mailing address is 3122 Sterling Circle, Suite 200 Boulder CO 80301 CO

Nivalis Therapeutics, Inc Insider Trading

  • The most recent transaction was 17,806 units bought on June 22, 2017 by Pil Partners Bvf, Fund Value Biotechnology, Biotechnology Value Fund Ii Lp, Biotechnology Value Trading Fund Os Lp, Bvf Partners Os Ltd, Incil Bvf and Mark Lampert worth over $40.06K
  • In the last 2 years, insiders at Nivalis Therapeutics, Inc sold an estimated value of $89.23K and bought an estimated value of $12.58M
  • The most active traders are Robert Conway, Director,  Jon Congleton, President and CEO,  and Biotechnology Value Fund Ii Lp
  • Insider trading is most common in September, with the busiest year in 2015

Nivalis Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1